2S Pharma group was established in the last quarter of the nineteenth century and since that 2S Pharma group’s major field of activity is the importation, licensing, marketing and distribution of pharmaceuticals and medical products in Egypt.

2S Pharma group started its activities in the field of biological and plasma derived products in 1998 as the exclusive agent for CSL Bioplasma in Egypt, An Australian Company that produces a world class human plasma derived product.

CSL since then has acquired the assets and operations of ZLB Bioplasma in Bern, Switzerland and this was followed by the acquisition of the Behring plasma derived products assets and operations to form the currently known CSL Behring.

We import, license, promote and distribute CSL Behring products in Egypt with market share of between 30% and 40% for any product placed on the market. These products are mainly critical care products, coagulation therapies and immunology products.